Compounds > gliclazide
Page last updated: 2024-10-27

gliclazide and Liver Dysfunction

gliclazide has been researched along with Liver Dysfunction in 2 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Research Excerpts

ExcerptRelevanceReference
"Metformin treatment showed either small mean increases or decreases."2.71Changes in liver tests during 1-year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide. ( Belcher, G; Schernthaner, G, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belcher, G1
Schernthaner, G1
De Vigan, C1
Delporte, MP1
Thomas, M1
Perrault, M1

Trials

1 trial available for gliclazide and Liver Dysfunction

ArticleYear
Changes in liver tests during 1-year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide.
    Diabetic medicine : a journal of the British Diabetic Association, 2005, Volume: 22, Issue:8

    Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gliclazide; Glycated He

2005

Other Studies

1 other study available for gliclazide and Liver Dysfunction

ArticleYear
[Hypoglycemic complications of oral drug therapy of diabetes mellitus. 21 cases].
    La Nouvelle presse medicale, 1976, Apr-03, Volume: 5, Issue:14

    Topics: Age Factors; Aged; Diabetes Mellitus; Diabetic Coma; Drug Interactions; Female; Gliclazide; Glyburid

1976